257 related articles for article (PubMed ID: 37422464)
1. Defective efferocytosis by aged macrophages promotes STING signaling mediated inflammatory liver injury.
Hu H; Cheng X; Li F; Guan Z; Xu J; Wu D; Gao Y; Zhan X; Wang P; Zhou H; Rao Z; Cheng F
Cell Death Discov; 2023 Jul; 9(1):236. PubMed ID: 37422464
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage.
Rymut N; Heinz J; Sadhu S; Hosseini Z; Riley CO; Marinello M; Maloney J; MacNamara KC; Spite M; Fredman G
FASEB J; 2020 Jan; 34(1):597-609. PubMed ID: 31914705
[TBL] [Abstract][Full Text] [Related]
4. Aging aggravated liver ischemia and reperfusion injury by promoting STING-mediated NLRP3 activation in macrophages.
Zhong W; Rao Z; Rao J; Han G; Wang P; Jiang T; Pan X; Zhou S; Zhou H; Wang X
Aging Cell; 2020 Aug; 19(8):e13186. PubMed ID: 32666684
[TBL] [Abstract][Full Text] [Related]
5. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.
Chen R; Huang B; Lian M; Wei Y; Miao Q; Liang J; Ou Y; Liang X; Zhang H; Li Y; Xiao X; Wang Q; You Z; Chai J; Gershwin ME; Tang R; Ma X
J Hepatol; 2023 Dec; 79(6):1478-1490. PubMed ID: 37659731
[TBL] [Abstract][Full Text] [Related]
6. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK).
Thorp E; Vaisar T; Subramanian M; Mautner L; Blobel C; Tabas I
J Biol Chem; 2011 Sep; 286(38):33335-44. PubMed ID: 21828049
[TBL] [Abstract][Full Text] [Related]
7. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury.
Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008
[TBL] [Abstract][Full Text] [Related]
8. PM
Liang S; Sun Q; Du Z; Ren X; Xu Q; Sun Z; Duan J
Nanotoxicology; 2022 Apr; 16(3):290-309. PubMed ID: 35653618
[TBL] [Abstract][Full Text] [Related]
9. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.
Cai B; Thorp EB; Doran AC; Subramanian M; Sansbury BE; Lin CS; Spite M; Fredman G; Tabas I
Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6526-31. PubMed ID: 27199481
[TBL] [Abstract][Full Text] [Related]
10. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/Mertk signaling following brain injury.
Soliman E; Leonard J; Basso EK; Gershenson I; Ju J; Mills J; Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
Res Sq; 2023 Jun; ():. PubMed ID: 37461720
[TBL] [Abstract][Full Text] [Related]
11. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.
Cai B; Thorp EB; Doran AC; Sansbury BE; Daemen MJ; Dorweiler B; Spite M; Fredman G; Tabas I
J Clin Invest; 2017 Feb; 127(2):564-568. PubMed ID: 28067670
[TBL] [Abstract][Full Text] [Related]
12. MLKL deficiency attenuated hepatocyte oxidative DNA damage by activating mitophagy to suppress macrophage cGAS-STING signaling during liver ischemia and reperfusion injury.
Xu J; Wu D; Zhou S; Hu H; Li F; Guan Z; Zhan X; Gao Y; Wang P; Rao Z
Cell Death Discov; 2023 Feb; 9(1):58. PubMed ID: 36765043
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis.
She Y; Xu X; Yu Q; Yang X; He J; Tang XX
Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511
[TBL] [Abstract][Full Text] [Related]
14. ER stress promotes mitochondrial calcium overload and activates the ROS/NLRP3 axis to mediate fatty liver ischemic injury.
Li F; Guan Z; Gao Y; Bai Y; Zhan X; Ji X; Xu J; Zhou H; Rao Z
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38497930
[TBL] [Abstract][Full Text] [Related]
15. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages.
Schilperoort M; Ngai D; Katerelos M; Power DA; Tabas I
Nat Metab; 2023 Mar; 5(3):431-444. PubMed ID: 36797420
[TBL] [Abstract][Full Text] [Related]
16. TLR4 is required for macrophage efferocytosis during resolution of ventilator-induced lung injury.
Su K; Bo L; Jiang C; Deng X; Zhao YY; Minshall RD; Hu G
Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L787-L801. PubMed ID: 34405715
[TBL] [Abstract][Full Text] [Related]
17. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
18. Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation.
Zhong W; Rao Z; Xu J; Sun Y; Hu H; Wang P; Xia Y; Pan X; Tang W; Chen Z; Zhou H; Wang X
Aging Cell; 2022 Jun; 21(6):e13622. PubMed ID: 35599014
[TBL] [Abstract][Full Text] [Related]
19. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
[TBL] [Abstract][Full Text] [Related]
20. MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.
DeBerge M; Yeap XY; Dehn S; Zhang S; Grigoryeva L; Misener S; Procissi D; Zhou X; Lee DC; Muller WA; Luo X; Rothlin C; Tabas I; Thorp EB
Circ Res; 2017 Sep; 121(8):930-940. PubMed ID: 28851810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]